Presentation + Paper
4 March 2022 The advantages and disadvantages of novel contrast agent types for fluorescence guided surgery
Author Affiliations +
Abstract
Rapid expansion in the field of fluorescence guided surgery (FGS) has yielded a wide range of contrast agent types under development with diverse characteristics. Currently, 105 active or completed clinical trials are registered in clinicaltrials.gov studying 39 unique novel FGS contrast agents. For these 39 contrast agents, there exists 6 distinct classes or types of probes: nanoparticle, antibody, protein, affibody, peptide, and small molecule. This diversity yields unique advantages and disadvantages among each type of contrast agent, which change throughout the various stages of development and clinical translation. In this review, we outline the relevant advantages and disadvantages for each type of FGS contrast agent at each stage of development. As the field continues to progress and expand, this diversity in FGS contrast agent type and their respective unique characteristics will enable broad applicability to shift the surgical paradigm and improve outcomes for patients across all surgical specialties.
Conference Presentation
© (2022) COPYRIGHT Society of Photo-Optical Instrumentation Engineers (SPIE). Downloading of the abstract is permitted for personal use only.
Connor W. Barth and Summer L. Gibbs "The advantages and disadvantages of novel contrast agent types for fluorescence guided surgery", Proc. SPIE 11943, Molecular-Guided Surgery: Molecules, Devices, and Applications VIII, 1194309 (4 March 2022); https://doi.org/10.1117/12.2613182
Advertisement
Advertisement
RIGHTS & PERMISSIONS
Get copyright permission  Get copyright permission on Copyright Marketplace
KEYWORDS
Molecules

Proteins

Safety

Clinical trials

Surgery

Nanoparticles

Tissues

RELATED CONTENT


Back to Top